Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (South&CentralAsia)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (South&CentralAsia)
Expanding variety at Royal Albert Hall | Brief letters
19/10/2025
Nicolas Sarkozy to enter prison for criminal conspiracy over Libyan funding
19/10/2025
Martin Mansergh obituary
19/10/2025
William Haggas criticises Oisin Murphy for ‘professional foul’ riding tactics
19/10/2025
Tom Gauld on limited editions – cartoon
19/10/2025
Houthi rebels detain 20 UN staff in Yemen
19/10/2025